We are live on ! Find out more
CIA

Capital Impact Advisors Portfolio holdings

AUM $247M
1-Year Est. Return 31.15%
This Fund
S&P 500
This Quarter Est. Return
+11.75%
1 Year Est. Return
+31.15%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$90.9M
AUM Growth
+$9.39M
Cap. Flow
+$2.51M
Cap. Flow %
2.76%
Top 10 Hldgs %
11.75%
Holding
179
New
2
Increased
99
Reduced
24
Closed
5

Top Buys

Rank Stock Value
1
UTHR icon
United Therapeutics
UTHR
+$777K
2
MTCH icon
Match Group
MTCH
+$705K
3
CLH icon
Clean Harbors
CLH
+$478K
4
ARVN icon
Arvinas
ARVN
+$443K
5
CHEF icon
Chefs' Warehouse
CHEF
+$406K

Top Sells

Rank Stock Value
1
SMCI icon
Super Micro Computer
SMCI
+$760K
2
APLS
Apellis Pharmaceuticals
APLS
+$721K
3
LMAT icon
LeMaitre Vascular
LMAT
+$553K
4
SWAV
Shockwave Medical, Inc. Common Stock
SWAV
+$537K
5
KMI icon
Kinder Morgan
KMI
+$521K

Sector Composition

Rank Sector Weight
1 Healthcare 31.93%
2 Technology 22.89%
3 Consumer Discretionary 12.96%
4 Industrials 10%
5 Financials 5.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VCYT icon
76
Veracyte
VCYT
$4.45B
$549K 0.6%
21,550
+8,893
+70% +$216K
TTEC icon
77
TTEC Holdings
TTEC
$124M
$537K 0.59%
15,857
+4,284
+37% +$147K
CNK icon
78
Cinemark Holdings
CNK
$4.07B
$532K 0.58%
32,215
+10,838
+51% +$180K
EVR icon
79
Evercore
EVR
$11.8B
$530K 0.58%
4,288
+217
+5% +$25K
WIRE
80
DELISTED
Encore Wire Corp
WIRE
$528K 0.58%
2,840
+295
+12% +$50K
YELP icon
81
Yelp
YELP
$1.54B
$520K 0.57%
14,277
+814
+6% +$26.3K
PD icon
82
PagerDuty
PD
$830M
$508K 0.56%
22,608
+715
+3% +$19.9K
APLS
83
DELISTED
Apellis Pharmaceuticals
APLS
$508K 0.56%
5,574
-8,360
-60% -$721K
TITN icon
84
Titan Machinery
TITN
$420M
$504K 0.55%
17,087
+2,602
+18% +$78.4K
ZYXI
85
DELISTED
Zynex
ZYXI
$503K 0.55%
52,403
+2,081
+4% +$21.6K
KRTX
86
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$494K 0.54%
2,279
+136
+6% +$29.1K
MDGL icon
87
Madrigal Pharmaceuticals
MDGL
$12.6B
$494K 0.54%
2,139
-753
-26% -$204K
HSTM icon
88
HealthStream
HSTM
$863M
$494K 0.54%
20,110
+926
+5% +$23K
FNKO icon
89
Funko
FNKO
$346M
$490K 0.54%
45,323
-16,424
-27% -$181K
PHR icon
90
Phreesia
PHR
$689M
$489K 0.54%
15,771
+781
+5% +$24.4K
EGRX
91
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$489K 0.54%
25,136
+11,529
+85% +$274K
BBIO icon
92
BridgeBio Pharma
BBIO
$16.4B
$476K 0.52%
27,666
– –
FNA
93
DELISTED
Paragon 28, Inc.
FNA
$473K 0.52%
26,678
+7,977
+43% +$143K
PI icon
94
Impinj
PI
$4.24B
$472K 0.52%
5,265
-498
-9% -$53.1K
SIG icon
95
Signet Jewelers
SIG
$3.84B
$469K 0.52%
7,187
+737
+11% +$51K
SUPN icon
96
Supernus Pharmaceuticals
SUPN
$2.7B
$469K 0.52%
15,598
– –
NTLA icon
97
Intellia Therapeutics
NTLA
$1.51B
$464K 0.51%
11,378
+673
+6% +$27.3K
ACAD icon
98
Acadia Pharmaceuticals
ACAD
$4.51B
$464K 0.51%
19,372
– –
ARHS icon
99
Arhaus
ARHS
$1.07B
$463K 0.51%
44,384
+3,768
+9% +$30.8K
CRSP icon
100
CRISPR Therapeutics
CRSP
$4.69B
$461K 0.51%
8,205
– –
2 3
4
5 6

Similar funds

AI
AXS Investments Port Chester, New York $248M AUM 15.95% 1-Year Est. Return
AB
ANB Bank Denver, Colorado $247M AUM 19.59% 1-Year Est. Return
PWS
Peloton Wealth Strategists Indianapolis, Indiana $247M AUM 13.57% 1-Year Est. Return
BFM
Blacksheep Fund Management Co. Dublin, Ireland $247M AUM 8.75% 1-Year Est. Return
IFPG
Intrepid Financial Planning Group Carmel, Indiana $248M AUM 19.02% 1-Year Est. Return
SCM
Segra Capital Management Palm Beach, Florida $248M AUM 65.61% 1-Year Est. Return
GWS
Greykasell Wealth Strategies Danville, California $248M AUM 22.08% 1-Year Est. Return
MC
Mount Capital London, United Kingdom $248M AUM 4.81% 1-Year Est. Return

Capital Impact Advisors's Q2 2023 Portfolio in Review

As of Q2 2023, Capital Impact Advisors held 179 positions worth $90.9M, up 12% from $81.5M the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Trading was light in Q2 2023: portfolio turnover was 3.9%. Capital Impact Advisors opened 2 new positions and exited 5, leaving the 179-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, up from 31% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Capital Impact Advisors's largest Q2 2023 buy was United Therapeutics: 3,507 shares worth $774K.
  • Capital Impact Advisors added most to Match Group in Q2 2023, an estimated $705K increase.
  • Capital Impact Advisors's biggest Q2 2023 reduction was Super Micro Computer, cutting an estimated $760K.
  • Capital Impact Advisors fully exited Kinder Morgan in Q2 2023, selling an estimated $521K.
  • Capital Impact Advisors's ten largest holdings make up 12% of its $90.9M portfolio in Q2 2023.
  • Capital Impact Advisors opened 2 new positions and closed 5 in Q2 2023.
  • Capital Impact Advisors's portfolio value rose 12% quarter-over-quarter to $90.9M.

Based on Capital Impact Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.